PANShu 1,2 , SUNFei 1,2 , SHIHong-can 1,2
  • 1. Department of Thoracic Surgery, Medical College of Yangzhou University, Yangzhou 225001, Jiangsu, P. R. China;
  • 2. Translational Medicine Research Center of Yangzhou University, Yangzhou 225001, Jiangsu, P. R. China;
SHIHong-can, Email: shihongcan@hotmail.com
Export PDF Favorites Scan Get Citation

In vivo transplantation of tracheal grafts utilizes natural environment in vivo to improve cell adhesion, growth and scaffold properties, which can not only promote graft revascularization, but also induce immune tolerance and increase postoperative survival rate. Decellularized trachea with stem cells covering the outside layer and airway epithelial cells covering the inside layer can achieve complete mucosa re-epithelialization, cartilage cell growth and revascularization, using own body as a natural bioreactor to boost the maturity of tissue engineered trachea. Then transplantation at a normotopic in situ positioning is performed. This transplantation strategy provides a promising approach for the treatment of long-segment tracheal defects. This review focuses on the significance and research progress of constructing tissue engineered trachea in vivo.

Citation: PANShu, SUNFei, SHIHong-can. Research Progress of Constructing Tissue Engineered Trachea in Vivo. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2014, 21(4): 527-530. doi: 10.7507/1007-4848.20140149 Copy

  • Previous Article

    颜面部烧伤致食管自发性破裂一例
  • Next Article

    主动脉夹层患者于全身麻醉诱导时出现癫痫样发作一例